A Copper(Ⅱ) Complex Based on N-(4-hydroxybenzyl)-L-serine:Synthesis,Crystal Structure and Inhibitory Activity on PTP1B and TCPTP

A novel copper(Ⅱ) complex with the reduced Schiff base, Cu(L)_2]·H_2O(I, HL = N-(4-hydroxybenzyl)-L-serine), was prepared in aqueous solution and characterized by elemental analysis, FT-IR, electrospray ionization mass spectrometry and single-crystal X-ray diffraction. Complex I crystallizes in the orthorhombic system, space group P212121, with a = 8.9040(18), b = 9.1530(18), c = 24.891(5) ?, V = 2028.6(7) ?3, Z = 4, C_(20)H_(26) Cu N_2O_9, Mr = 501.97, Dc = 1.644g·cm3, μ = 1.135 mm-1, F(000) = 1044, GOOF = 1.194, the final R = 0.0484 and w R = 0.1420 for 6186 observed reflections(I 2σ(I)). In I, two L- anions are coordinated to the copper ion in tridentate and bidentate chelating modes, respectively, resulting in the coordinated geometry of copper ion to be a distorted square pyramid. The intermolecular hydrogen bonds between the complexes, complexes and lattice water molecules lead to a 2D supramolecular network. The bioactivity of the complex as a potential PTPs inhibitory agent in vitro was investigated, displaying potent inhibition against PTP1B(IC50, 0.27 μM) and TCPTP(IC50, 0.57 μM) with a moderate selectivity.